Overall, our study demonstrated that iron oxide nanoparticles combined with LOX generated a synergistic effect that reinvigorated the ratio of M1 macrophages and inhibition of cancer cells (Figure 7) as a potential anticancer therapy. The gene discussed is LOX; the disease is cancer.